Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma.
Friend BD, Muhsen IN, Patel S, Hill LC, Lulla P, Ramos CA, Pingali SR, Kamble RT, John TD, Salem B, Bhar S, Doherty EE, Craddock J, Sasa G, Wu M, Wang T, Martinez C, Krance RA, Heslop HE, Carrum G. Friend BD, et al. Among authors: bhar s. Bone Marrow Transplant. 2022 Apr;57(4):579-585. doi: 10.1038/s41409-022-01599-5. Epub 2022 Feb 1. Bone Marrow Transplant. 2022. PMID: 35105965
Gastric Adenocarcinoma in the Setting of IPEX Syndrome.
Steffin D, Bhar S, Fishman DS, Rider NL, Naik-Mathuria B, Martinez C, Venkatramani R. Steffin D, et al. Among authors: bhar s. Case Reports Immunol. 2021 Jun 25;2021:9967198. doi: 10.1155/2021/9967198. eCollection 2021. Case Reports Immunol. 2021. PMID: 34258086 Free PMC article.
Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
Laberko A, Deordieva E, Krivan G, Goda V, Bhar S, Kawahara Y, Rao K, Worth A, McDermott DH, Balashov D, Maschan A, Shcherbina A. Laberko A, et al. Among authors: bhar s. J Clin Immunol. 2022 Jan;42(1):171-182. doi: 10.1007/s10875-021-01155-8. Epub 2021 Oct 26. J Clin Immunol. 2022. PMID: 34697698 Free PMC article.
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival.
Martinez C, Aguayo-Hiraldo P, Chaimowitz N, Forbes L, Rider N, Nicholas S, Seeborg F, Chinen J, Chinn I, Davis C, Roseblatt H, Noroski L, Omer B, John T, Yassine K, Naik S, Craddock J, Bhar S, Allen C, Ahmed N, Sasa G, Steffin D, Doherty E, George A, Salem B, Friend B, Hegde M, Brenner MK, Heslop HE, Leen A, Peña A, Wu M, Hanson IC, Krance RA. Martinez C, et al. Among authors: bhar s. Blood Adv. 2023 May 9;7(9):1823-1830. doi: 10.1182/bloodadvances.2022009038. Blood Adv. 2023. PMID: 36453638 Free PMC article. Clinical Trial.
Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab.
Sánchez LM, George A, Friend BD, Bhar S, Sasa G, Doherty EE, Craddock J, Steffin D, Salem B, Yassine K, Omer B, Martinez C, Leung K, Krance RA, John TD. Sánchez LM, et al. Among authors: bhar s. Pediatr Hematol Oncol. 2024 May;41(4):260-272. doi: 10.1080/08880018.2023.2296933. Epub 2023 Dec 22. Pediatr Hematol Oncol. 2024. PMID: 38131101
A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy.
Ragoonanan D, Bhar S, Mohan G, Beltramo F, Khazal SJ, Hurley C, Andersen C, Margossian S, Neelapu SS, Shpall E, Gutierrez C, Tewari P, Shoberu B, Talleur A, McCall D, Nunez C, Cuglievan B, Tambaro FP, Petropoulos D, Abdel-Azim H, Mahadeo KM. Ragoonanan D, et al. Among authors: bhar s. Front Oncol. 2022 Oct 24;12:1022901. doi: 10.3389/fonc.2022.1022901. eCollection 2022. Front Oncol. 2022. PMID: 36353531 Free PMC article.
109 results